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ABSTRACT  Hyaluronate levels  change dramatically during morphogenesis  of various  tissues 
and organs. Morphological detection of the exact temporal and spatial distribution patterns of 
hyaluronate may help to elucidate its role in morphogenesis.  Since no specific direct method 
for visualizing  hyaluronate with  the light  or electron  microscope  is currently available,  we 
have developed a morphological probe by exploiting the high-affinity interaction of cartilage 
proteoglycan with hyaluronate. The core protein of this proteoglycan consists of a region that 
binds specifically to hyaluronate with a high association  constant, and a region to which the 
majority of sulfated polysaccharide chains are covalently attached. The polysaccharide chains 
were  removed  by treatment with  chondroitinase ABC,  and  the core  protein,  labeled with 
rhodamine, was used as the probe. This fluorescent probe binds reversibly and specifically to 
[3H]hyaluronate in a binding assay using ammonium sulfate precipitation of the core protein. 
The probe has been used to visualize  the cell surface  hyaluronate of rat fibrosarcoma cells, 
3T3 cells, and SV-40 transformed 3T3 cells, three cell types with significantly different amounts 
of cell surface-associated hyaluronate. 
Morphological localization of the spatial pattern of extracel- 
lular matrix molecules is necessary to attain a better under- 
standing of their function in developing, remodeling, diseased 
and normal adult tissues.  Antibodies to proteins of the extra- 
cellular matrix, such as fibronectin (1, 2), laminin (3-5), and 
the various collagen types (6-9), have been used extensively 
to map their location in vivo and to facilitate the development 
and testing of models for their interactions with other com- 
ponents  of the  matrix  as  well  as  with  cells.  Many  of the 
proteoglycans present in  the  extracellular matrix  have also 
been localized by the use of antibodies to their specific core 
proteins ( 10,  1 l). However hyaluronate, a glycosaminoglycan 
(GAG)  j  which  is  commonly present  in  tissues  undergoing 
morphogenesis or remodeling (reviewed in references 12 and 
13), probably exists in these tissues as a free GAG polymer to 
which antibodies have not yet been successfully raised. 
To date,  no  specific direct  stain  has  been  developed  to 
visualize  hyaluronate  in  the  light  or  electron  microscope. 
Previous attempts  to  determine  the  spatial  distribution  of 
hyaluronate  have  relied  upon  differences  in  staining  with 
Alcian  blue  (14,  15)  or  [3H]glucosamine autoradiographic 
grains (16)  before and after treatment with  hyaluronidases. 
These methods are most successful when applied to a matrix 
~  Abbreviations  used in  this paper.  GAG, glycosaminoglycan; RFS, 
rat fibrosarcoma; SV-3T3, simian virus-40 transformed 3T3. 
composed  mainly  of hyaluronate,  since  in  more  complex 
matrices other GAGs react with Alcian blue or incorporate 
[3H]glucosamine,  thus  increasing  the  background  staining. 
Localizing hyaluronate in fetal or adult tissue that contained 
several GAG types would  be  facilitated by use  of a  more 
specific stain for hyaluronate. 
During tissue fixation,  hyaluronate and  other GAGs are 
often  extracted,  which  distorts  spatial  relationships  in  the 
tissue.  In recent years, improved fixation techniques,  most 
commonly using  tannic  acid  or  cetylpyridinium  chloride, 
reduce the extraction of GAG.  However, use of the  heavy 
metal mordant tannic acid in fixatives to localize hyaluronate 
is complicated by the problem of nonspecificity of its inter- 
actions with mucins and other complex carbohydrates (17). 
Cetylpyridinium chloride used in fixation procedures also is 
not  specific for hyaluronate and  will  precipitate all GAGs. 
The precipitates that form within tissues often disrupt cellular 
integrity and alter the organization of matrix components (18, 
19). 
In this paper, we describe the development of a fluorescent 
probe for hyaluronate that exploits the interaction of cartilage 
proteoglycan with hyaluronate. The core protein of this pro- 
teoglycan consists of a  region that binds specifically to hya- 
luronate with a high association constant (20),  and a region 
to which the majority of chondroitin sulfate chains are cova- 
lently attached (21 ). The polysaccharide chains were removed 
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labeled with rhodamine, was used as the probe. In an alter- 
native probe preparation, the hyaluronate-binding region of 
the  core protein  was used.  The  fluorescent probes interact 
directly with hyaluronate and are applicable to use with frozen 
tissue sections, thus eliminating GAG extraction and distor- 
tion due to fixation. In this communication, the fluorescent 
probe has been utilized to visualize the cell surface-associated 
hyaluronate of three cell types that have been found previ- 
ously to have distinct differences in cell surface hyaluronate 
(22): rat fibrosarcoma (RFS) cells, 3T3 cells, and simian virus- 
40 transformed 3T3  (SV-3T3) cells.  Also,  the specificity of 
the probe was analyzed with a  specific hyaluronate-binding 
assay, and by the removal or inhibition of staining by com- 
peting agents or enzyme treatment. 
MATERIALS  AND  METHODS 
Extraction and Purification of Proteoglycan Monomer:  Calf 
scapular cartilage was ground to a powder in a Wiley mill under liquid nitrogen, 
The powder was extracted with 9 vol 4.0 M guanidine hydrochloride (practical 
grade, Sigma Chemical  Co., St.  Louis, MO), 0.05 M sodium acetate (Sigma 
Chemical Co.), pH 5.8, which contained  the following protease inhibitors:  10 
mM ethylenediaminetetraacetic  acid disodium salt (Sigma Chemical Co.), 100 
mM 6-amino-hexanoic acid (Sigma Chemical Co.), 5 mM benzamidine hydro- 
chloride  (Kodak  Laboratory,  Eastman  Kodak  Co.,  Rochester,  NY),  2  mM 
phenylmethylsulfonyl fluoride (Calbiochem-Behring Corp., La Jolla, CA). This 
solution will be referred to as 4 M GuHCI buffer with protease inhibitors. The 
cartilage extract was stirred for 90 h at 4"C, centrifuged for 45 min at 13,000 g 
(10,500 rpm in a Sorvall SS-34 rotor,  Beckman Instruments,  Inc., Palo Alto, 
CA), and the supernatant  was dialyzed against several changes of water for 24 
h at 4"C. The material was centrifuged again at  13,000 g for 30 min and the 
supernatant,  which contained proteoglycan aggregate, was lyophilized. 
To separate proteoglycan  monomer from hyaluronate  and link protein,  a 
dissociative CsC1 gradient was performed according to Hascall and Heinegard 
(23). 300 mg of proteoglycan aggregate was dissolved in 150 ml of 4 M GuHC1 
buffer with protease inhibitors plus 3 M CsC1 (Accurate Chemical & Scientific 
Corp., Westbury, NY). The pH was maintained  at 5.8. The final density was 
1.5  g/ml. Density gradient  centrifugation  was carried out for 65  h at 4"C at 
128,000  g  (40,000  rpm  in  a  70  Ti  rotor)  in  a  preparative  ultracentrifuge 
(Beckman Instruments, Inc.). The gradient was divided into three equal frac- 
tions; the  bottom fraction, which contained  proteoglycan monomer, was di- 
alyzed against water and lyophilized. 
Preparation of ehodamine-conjugated  Core  Protein:  To 
form aggregates, 2 mg of hyaluronate  (Grade  III, Sigma Chemical  Co.) was 
added  to  35  mg of proteoglycan  monomer dissolved  in  3  ml  of 0.01 M 
phosphate buffer, pH 9.3, and the mixture was stirred for 2 h on ice. Rhodamine 
conjugation was done after a modification of the method reported by Fujiwara 
and Pollard (24). A solution of 1.5 mg rhodamine-B isothiocyanate (Grade II, 
Sigma Chemical Co.) dissolved in 0.5 ml of 0.01 M phosphate buffer, pH 9.3 
was mixed with the solution  of aggregate and stirred on ice for 4 h while the 
oH was maintained  at 9.3, The sample was allowed to stand for 15 h at 4"C, 
and was then dialyzed against several changes of 0.1  M Tris, 0.1  M sodium 
acetate  buffer,  pH  7.4, for  30  h  at 4"C, to remove  and inactivate  the  free 
rhodamine isothiocyanate  and to achieve the proper buffering conditions  for 
the  following enzyme  digestion.  100  ~1  of a  solution  of  10  U/ml each  of 
chondroitinase  AC (Sigma Chemical  Co.) and  chondroitinase  ABC (Sigma 
Chemical Co.) in 0.1  M Tris, 0. I M sodium acetate buffer, pH 7.4 was added 
and the sample digested for 18  h at 37"C. It was then dialyzed against 4 M 
GuHCI buffer with protease inhibitors at 4"C for 24 h. The mixture was passed 
through a Sephacryl S-200 column which had been preequilibrated with the 4 
M GuHCI buffer with protease inhibitors, to separate the rhodamine-conjugated 
core  protein  from the  hyaluronate  and  chondroitin  sulfate  fragments.  The 
rhodamine-conjugated  core  protein  eluted  in  the  Vo  fraction,  whereas  the 
fragments from the chondroitinasc  digestion eluted at the total volume.  The 
dye/protein  ratio for the rhodamine-conjugated  core protein was 1.73. 
Preparation of Rhodamine-conjugated  Hyaluronate-bind- 
ing Fragment:  After the rhodamine conjugation and dialysis described in 
the previous section, a limited trypsin (0.0275 mg/ml, Type II, Sigma Chemical 
Co.) digestion was carried out for 2 h at 37"C, and the reaction was terminated 
by the  addition  of soybean trypsin  inhibitor  (0.26 mg/ml, Type  I-S, Sigma 
Chemical Co.), The sample was dialyzed against a 4  M GuHCI buffer with 
protease inhibitor's at 4"C for 24 h, and then passed through a Scphacryl S-20fl 
column in the same buffer to separate hyaluronate and the chondroitin  sulfate- 
rich region of the proteoglycan monomer from the hyaluronate-binding region 
of the proteoglycan monomer. These three components eluted at K,v = 0, K,v 
= 0.07, and Kov = 0.64, respectively. The dye/protein  ratio for the rhodamine- 
conjugated hyaluronate-binding  fragment was 0.64. 
Hyaluronate Binding Assay:  This  assay, a  modification  of that 
reported  by  Underhill  et  al.  (25), is based  on the reversible binding  of the 
rhodamine-conjugated  core protein  to [3H]hyaluronate and uses ammonium 
surface precipitation of the fluorescent probe. The complex of [JH]hyaluronate 
with the fluorescent probe precipitates, whereas free [3H]hyaluronate remains 
in the  supernatant.  The rhodamine-conjugated  core protein  (protein  content 
determined  by Lowry et al. [26]) was mixed with [3H]hyaluronate in  1.5-ml 
microcentrifuge  tubes (Eppendorf)  and the final volume  adjusted  to 0.5  ml 
with Ca  ++- and Mg÷*-free phosphate-buffered saline (PBS). The mixture con- 
tained  varying  amounts of the  fluorescent  probe  (2.5-60  ,~g), 3  ug  [3HI- 
hyaluronate  (prepared according to Underhill  and Topic, reference [27]), 0.5 
M NaCl, 0.02 M Tris, pH 8.0. The background was determined by including a 
large excess of high molecular weight unlabeled hyaluronate (500 t@/ml, Grade 
I, Sigma Chemical Co.). Samples were shaken at 25"C for 3 h. Casein (l  rag, 
Sigma Chemical Co.) was added as a protein carrier, and the protein-hyaluro- 
nate  complex  precipitated  with  an  equal  volume  of saturated  ammonium 
sulfate. After mixing, the samples were centrifuged  for  l0 rain  at  12,000 g 
(Microfuge B,  Beckman Instruments,  Inc.). The supernatants  were aspirated 
and the pellets rinsed three times with 50% saturated  (NH4)2SO4. The pellets 
were solubilized in 0.2 M NaOH, the pH of the resulting solutions neutralized, 
and the radioactivity determined  by scintillation counting. 
Fixation and Staining of Cells:  Most  of the studies on the hyalu- 
ronate  probe  presented  here  were performed  with  formaldehyde-fixed  RFS 
cells. We also compared the interaction  of the probe with formaldehyde-fixed 
3T3  and  SV-3T3 cells.  Cells were  grown  in  Dulbecco's  modified  Eagle's 
medium, which contained 4.5 mg/ml glucose, 10% fetal bovine serum (Gibco 
Laboratories, Grand Island, NY) plus 1%  penicillin and streptomycin.  Ceils 
were subcultured at low density, 2 x  10  ~ cells/ml, into miniwell culture dishes 
(Costar Corp., Cambridge, MA) containing glass coverslips (Bellco Glass Inc., 
Vineland, N  J) and allowed to attach and spread for 1 d. Cells were washed in 
PBS containing Ca  +* and Mg  "+ and fixed in 2% formaldehyde (Fisher Scientific 
Co., Pittsburgh, PA) in PBS, pH 7.4, for 15 min at 25"C, washed and incubated 
with 180 #l of a solution of the fluorescent probe at various concentrations  in 
PBS. The coverslip was washed and inverted on a glass slide using glycerin with 
10% PBS as a support medium. A Zeiss IM 35 inverted microscope (Carl Zeiss, 
Inc., Thornwood,  NY) equipped  with phase contrast  and  bright field optics 
with Ploem type epiillumination  and appropriate  filter combinations for visu- 
alizing rhodamine was used for observations and photography. All photographs 
were taken  on  the  same  microscope,  with  the same emission  and  time  of 
exposure and ASA, developed with the same procedure, and printed to obtain 
a consistent background. 
RESULTS AND  DISCUSSION 
Staining of RFS Cells with Rhodamine-conjugated 
Core Protein 
RFS cells were used for the initial characterization of the 
specificity of the  fluorescent probe since they have a  large 
amount of cell  surface-associated hyaluronate,  0.90 #g/10  ~ 
cells; in comparison, 3T3 ceils have 0.33 #g, and SV-3T3 cells 
FIGURE  1  Staining  of formaldehyde-fixed RFS cells  with  rhodamine-conjugated core protein. (a, c,  e,  and  g)  Fluorescence 
microscopy images; (b, d, f, and h) phase contrast images of the same fields as a, c, e, and g, respectively.  This heterogeneous 
cell line exhibits two typical morphologies, one very flattened, and the other more round with long filopodia. A few of the very 
flattened cells exhibited diminished staining, but variability in staining is not common. Cells were incubated with: (a and b) 3.5 
~g of the hyaluronate probe for 3 h; (c and d) 3.5 #g of the hyaluronate probe for 3 h, then washed and treated with Streptomyces 
hyaluronidase;  (e and f) 3.5 ~g of the hyaluronate probe together with exogenous hyaluronate for 3 h; (g and h) 3.5 #g of the 
hyaluronate probe together with exogenous, nonconjugated core protein for 3 h. x  275. 
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Binding  of  [3H]hyaluronate  to  rhodamine-conjugated 
core protein. 3 #g [3H]hyaluronate was added to varying amounts 
of the fluorescent probe as described in Materials and Methods. All 
values represent the average of triplicate or quadruplicate deter- 
minations  minus  the  nonspecific  background.  Background  was 
measured  by  addition  of  500  /~g  unlabeled  hyaluronate  to  the 
reaction mixture. 
have 0.01  #g hyaluronate per  106 cells  (22).  RFS cells  were 
incubated with the rhodamine-conjugated core protein probe 
using various concentrations of probe and times of incuba- 
tion. The appearance of visible fluorescence was found to be 
dependent on both parameters (Table I). On the basis of these 
TABLE  I 
Dependence  of Staining on Time and Probe Concentration 
/Lg Probe 
Time  0.35  0.7  1.75  3.5  5.25  7.0 
h 
O.25  .....  + 
0.5  .....  + 
0.75  ....  +  + 
1  -  -  -  +  +  + 
3  +  +  +  +  +  + 
5  +  +  +  +  +  + 
Formaldehyde-fixed RFS cells were incubated  with the above probe concen- 
trations  for varying time intervals. -, no detectable fluorescence;  +, detect- 
able fluorescence. 
FIGURE  3  Comparison  of  staining  by  rhodamine-conjugated  hyaluronate-binding and  chondroitin  sulfate-rich  fragments  of 
cartilage  proteoglycan.  (a  and  c)  Fluorescence  images;  (b  and  d}  phase-contrast  images.  Formaldehyde-fixed  RFS  cells  were 
stained with: (a and b) 7/Lg rhodamine-conjugated, hyaluronate-binding fragment for 3 h; or, (c and d) 7/~g rhodamine-conjugated 
chondroitin sulfate-rich  fragment for 3 h. x  275. 
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#g of probe for 3 h at 25"C.  Staining under these conditions 
is shown in Fig.  1  a. Staining was inhibited by (a) treatment 
of the cells with enzymes such as Streptomyces  hyaluronidase, 
which degrades hyaluronate specifically (28, and Fig.  1 c), (b) 
competition with exogenous hyaluronate (Fig.  1 e), and  (c) 
competition with nonconjugated  core protein (Fig.  1 g). In 
each case, titrations were performed to determine the mini- 
mum concentrations for inhibition of staining. 
TAate  II 
Staining of 3T3 and SV-3T3  Cells 
gg Probe 
Time  0.35  0.7  1.75  3.5  5.25  7.0 
h 
3T3 Cells 
I  .....  + 
3  -  +  +  +  +  + 
SV-3T3 Cells 
1  .....  + 
3  -  -  -  +  +  + 
Formaldehyde-fixed 3T3  and  SV-3T3 cells  were incubated with the above 
probe concentrations for varying  time  intervals.  -,  no observable fluores- 
cence; +, observable fluorescence, 
Staining by the fluorescent probe was prevented if the cells 
were preincubated for 30 min at 37"C with minimum concen- 
trations  of 0.01  U/ml  Streptomyces hyaluronidase  (Calbi- 
ochem-Behring  Corp.),  0.1  ng/ml  testicular  hyaluronidase 
(Type l-S, Sigma Chemical Co.), or 0.05 U/ml chondroitinase 
AC-ABC (Sigma Chemical Co.). If the cells were first incu- 
bated with the probe, then treated with Streptomyces  hyalu- 
ronidase, staining was removed. The fluorescent probe might 
be expected to bind to free link protein in tissues (23),  but 
such staining would not be removed by treatment with hyalu- 
ronidases. 
Staining was inhibited by competition with nonconjugated 
core protein; no fluorescence was seen at ratios of nonconju- 
gated-to-conjugated core protein  of 32:i  or higher.  Similar 
titrations that used exogenous hyaluronate showed that con- 
centrations of 0.3 mg/ml or greater were inhibitory for stain- 
ing RFS cells when 3.5 ug of the fluorescent probe was used. 
However, chondroitin sulfate (Grade III, Sigma Chemical Co., 
pretreated with Streptomyces hyaluronidase to  remove any 
contaminating hyaluronate and then boiled) was not inhibi- 
tory at a concentration of 1.5 mg/ml. Inhibition of staining 
was obtained with nonconjugated core protein or with hya- 
luronate  at  the  above-mentioned concentrations  when  the 
cells were  incubated  with  the  probe and  competing agent 
together, and staining was removed when the cells were first 
incubated with the probe for 3 h, washed, and then incubated 
F~GU~E  4  Staining of formaldehyde-fixed (a and b) 3T3 ce]Is and (c and d) SV-3T3 ce]Is. In both cases, the ceIIs were incubated 
for 3 h with 3.5/~g rhodamine-conlugated core protein. (a and c)  Fluorescence images; (b and d) phase-contrast images, x  275. 
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To confirm the specific binding of the fluorescent probe to 
hyaluronate, we also tested binding biochemicalty using the 
ammonium sulfate precipitation  assay.  Increasing  amounts 
of [3H]hyaluronate were bound as the protein concentration 
increased (Fig. 2). Competition of [3H]hyaluronate binding to 
the probe was obtained with the addition of excess unlabeled 
hyaluronate.  Addition  of excess  chondroitin  sulfate (Grade 
III, Sigma Chemical Co., pretreated with Streptomyces hya- 
iuronidase and then boiled) at equal or greater concentrations 
(1-2  mg/ml) did  not block  [3H]hyaluronate binding  to the 
probe. 
Staining of RFS Cells with Rhodamine-conjugated 
Hyaluronate-binding Fragment 
In an alternative protocol, the chondroitin sulfate-rich and 
hyaluronate-binding regions of proteoglycan monomer were 
separated by gel  filtration  after limited  trypsin  digestion  of 
the  rhodamine-conjugated monomer.  Both  fragments were 
shown to contain conjugated rhodamine molecules. However, 
only the  rhodamine-conjugated hyaluronate-binding region 
stained the RFS cell surface hyaluronate, as shown in Fig.  3 
a. The fluorescent signal obtained with this probe was weaker 
than that with the rhodamine-conjugated core protein (Fig.  1 
a). This was probably due to the lower dye/protein  ratio of 
the hyaluronate-binding fragment probe. However, an advan- 
tage of the rhodamine-conjugated hyalurortate-binding frag- 
ment may be its smaller molecular weight which would allow 
better tissue penetration.  Incubation of cells with similar or 
higher  concentrations  of  the  rhodamine-conjugated  chon- 
droitin sulfate-rich region did not result in observed fluores- 
cence of the RFS cells (Fig.  3 c). 
Staining of 37-3 and SV-3T3 Cells with 
Rhodamine-conjugated Core Protein 
The staining of 3T3  cells and SV-3T3 cells was compared 
using  several  concentrations  of  the  rhodamine-conjugated 
core protein probe.  SV-3T3  cells,  which have  30  times less 
cell  surface-associated  hyaluronate than  3T3  ceils (22),  re- 
quired higher probe concentrations to  observe fluorescence 
than the 3T3 cells (Table II); thus, qualitatively, the intensity 
appears to parallel the chemically determined amounts of the 
cell  surface  hyaluronate.  At  those  concentrations of probe 
where both cell types showed staining, the intensity of staining 
of the 3T3 cells was greater when assessed subjectively. In Fig. 
4, 3T3 and SV-3T3 cells were incubated with the rhodamine- 
conjugated core protein under identical conditions at such a 
concentration, showing the stronger staining of 3T3 than SV- 
3T3 cells. 
In summary, our preliminary results reported here demon- 
state  the  development  of  a  specific  fluorescent  probe  for 
hyaluronate. The probe, conveniently prepared from cartilage 
proteoglycan  isolated  by  standard  techniques,  directly  and 
specifically  stains  hyaluronate.  Future  applications  of  the 
fluorescent probe may help to elucidate the role of hyaluro- 
nate in  morphogenesis and tumorigenesis by demonstrating 
detailed temporal  and spatial patterns.  The  probe has been 
used successfully with paraffin sections of chick embryo tis- 
sues (Toole, B.  P., and E.  Beisky, unpublished observations) 
and  should  be  readily  applicable  to  use  with  frozen tissue 
sections, thus eliminating GAG extraction and distortion due 
to fixation. Studies in progress include the use of the fluores- 
cent  probe  to  localize hyaluronate at  the  connective  tissue 
1 758  T~  ~ouR~^t  o~  cm  a~o~ocv,  votw~  ~00, ~985 
interface between tumor and neighboring host tissue (29) and 
in the granule cell layer and other specific regions of normal 
and mutant mouse brains (30). 
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